Sue-Anne McLachlan COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Patients' and their doctors’ preferences for adjuvant chemotherapy (ACT) in early non-small cell lung cancer (NSCLC): What makes it worthwhile? — COSA Best of the Best Orals: Health Services